Robert Alexander Ingram - Feb 28, 2022 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Feb 28, 2022
Transactions value $
$18,736
Form type
4
Date filed
3/2/2022, 03:40 PM
Previous filing
Dec 17, 2021
Next filing
Mar 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $18.7K +1.13K +1.43% $16.61 80.1K Feb 28, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750.